Pfizer's quit-smoking Chantix fails study in adolescent smokers
(Reuters) - Pfizer Inc said on Friday its study to test safety and effectiveness of its anti-smoking treatment Chantix in adolescent smokers failed to meet the main goal.
from Reuters: Health News http://reut.rs/2G2rxuE
http://bit.ly/2zwRqiM